Rising Cannabis Use Disorder Reports Don't Justify Prohibition Return

The Numbers Behind the Headlines

Emergency department visits coded for cannabis use disorder rose 23% in legal states between 2022 and 2025, but that figure masks context. Most of those visits involve co-occurring conditions—anxiety, trauma, chronic pain—where cannabis is one variable among many. The diagnostic code doesn't distinguish between daily high-dose consumption and occasional use flagged during intake screening.

Treatment admissions tell a different story. Voluntary enrollment in cannabis-focused programs increased 14% over the same period, while court-mandated referrals dropped 9%. That shift suggests people are seeking help on their own terms, not because prohibition's enforcement machinery pushed them into the system.

What Problematic Use Actually Looks Like

Cannabis use disorder is real, but it's not the reefer madness narrative. The condition affects an estimated 9% of regular users—comparable to alcohol's rate among drinkers. Symptoms include tolerance, failed quit attempts, and interference with daily responsibilities. It's a clinical picture. Not a moral one.

The question isn't whether some people struggle with cannabis. It's whether prohibition ever reduced that struggle—or just made it invisible.

Pre-legalization data is sparse because users avoided clinical settings. Now that possession is legal in 24 states, people show up. That's a feature of good policy, not a bug.

The Prohibition Counterfactual Nobody Wants

Returning to criminalization would trade one public health challenge for a larger civil rights catastrophe. Between 2010 and 2020, cannabis arrests topped 6 million nationwide. Black Americans were arrested at 3.6 times the rate of white users despite near-identical consumption rates. Those records block housing, employment, and education access for decades.

The math is brutal: trading a 9% disorder rate among users for a 100% criminalization rate among arrestees isn't harm reduction. It's harm redistribution.

What Evidence-Based Response Looks Like

States can address problematic use without dismantling legal markets. Colorado allocated $9.2 million in cannabis tax revenue to treatment programs in 2025, funding same-day intake and sliding-scale counseling. Washington's cannabis education campaign reduced youth initiation rates by 11% over three years without a single arrest.

Regulation creates levers prohibition never had: potency caps, serving-size limits, mandatory lab testing, and revenue streams for public health infrastructure. Those tools don't exist in the illicit market.

The Path Forward

The debate isn't legalization versus prohibition—it's what kind of legalization we build. Some MSOs push 90%-THC concentrates with no dosage guidance. Some dispensaries train budtenders in harm reduction; others optimize for basket size. The policy question is whether we regulate those gaps or surrender the market to whoever's willing to ignore them.

For a fuller look at the clinical research and state-by-state treatment data, see the CannIntel topic hub on cannabis use disorder. The next signal to watch: whether federal rescheduling under the DEA's pending NPRM creates Medicaid reimbursement pathways for cannabis-specific treatment. That would be the largest structural shift in access since legalization began.